Concepedia

Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes

Hideto Tamura, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Asaka Kondo, Hideya Hyodo, Kyoko Nakamura,

Leukemia Research · 2010 · 29 citations · 28 references

Concepts

MedicineHematologyImmunologyHematopathologyImmunogeneticsImmunopathologyAutoimmune Hematologic DiseaseBone Marrow EvaluationBone Marrow PathologyHematopoietic NeoplasmsMyelodysplastic SyndromesHigher-risk Myelodysplastic SyndromesMyelodysplastic Syndrome AssessmentMyelodysplastic Syndrome TherapyMyelodysplastic Syndrome TreatmentPeripheral Blood Lymphocyte AnalysisWt1 Gene Alterations

References

28

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text

Medicine, Hematology, Internal Medicine +13

Proposals for the classification of the myelodysplastic syndromes

John M. Bennett, Daniel Catovsky, MT Daniel et al. · British Journal of Haematology · 1982 · 3.7K citations

Medicine, Hematology, Pathology +12

Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

Luca Malcovati, Ulrich Germing, Andrea Kuendgen et al. · Journal of Clinical Oncology · 2007 · 1K citations

Public Health, Biostatistics, Hematology +17

Efficacy of Lenalidomide in Myelodysplastic Syndromes

Alan F. List, S. Kurtin, Denise J. Roe et al. · New England Journal of Medicine · 2005 · 876 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia

Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa et al. · Blood · 1994 · 575 citations · Full text

Medicine, Hematology, Oncology +16